Worldwide Botulinum Toxins Industry to 2026 – Increasing Number of Product Approvals and Launch of Novel Products Presents Opportunities

DUBLIN, Sept. 30, 2021 /PRNewswire/ — The «Botulinum Toxins Market Research Report by Application, by Region – Global Forecast to…

DUBLIN, Sept. 30, 2021 /PRNewswire/ — The «Botulinum Toxins Market Research Report by Application, by Region – Global Forecast to 2026 – Cumulative Impact of COVID-19» report has been added to’s offering.

Research and Markets Logo

The Global Botulinum Toxins Market size was estimated at USD 3,230.60 Million in 2020 and expected to reach USD 3,713.68 Million in 2021, at a Compound Annual Growth Rate (CAGR) 15.29% to reach USD 7,587.03 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies – USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Botulinum Toxins Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Botulinum Toxins Market, including AbbVie Inc., Ajinomoto Bio-Pharma Services, Bausch Health Companies Inc., Daewoong Pharmaceuticals Co.Ltd., Eisai Co., Ltd, Galderma S.A., Gufic Biosciences Ltd., Hugel, Inc, Hugh Source International Ltd., Ipsen group, JUVAPLUS, Lanzhou Institute of Biological Products Co. Ltd., List Biological Labs, Inc, Medytox Inc., Merz GmbH & Co. KGaA, Object Pharma, Inc., Pfizer Inc., Revance Therapeutics, Inc., Shanghai Haohai Biological Technology Co., Ltd., and US Worldmeds, LLC.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Botulinum Toxins Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Botulinum Toxins Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Botulinum Toxins Market?

4. What is the competitive strategic window for opportunities in the Global Botulinum Toxins Market?

5. What are the technology trends and regulatory frameworks in the Global Botulinum Toxins Market?

6. What is the market share of the leading vendors in the Global Botulinum Toxins Market?

7. What modes and strategic moves are considered suitable for entering the Global Botulinum Toxins Market?

Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Cumulative Impact of COVID-19

5. Market Insights

5.1. Market Dynamics

5.1.1. Drivers Rising number of non-invasive cosmetic procedures Increasing individuals highly conscious of their appearance Rising aging population demand for procedures to make their skin look young

5.1.2. Restraints Relatively high cost of the procedure

5.1.3. Opportunities Increasing number of product approvals and launch of novel products Surging awareness of therapeutic and cosmetic application of botulinum toxin

5.1.4. Challenges Probable side effects of the procedure

5.2. Porters Five Forces Analysis

5.2.1. Threat of New Entrants

5.2.2. Threat of Substitutes

5.2.3. Bargaining Power of Customers

5.2.4. Bargaining Power of Suppliers

5.2.5. Industry Rivalry

6. Botulinum Toxins Market, by Application

6.1. Introduction

6.2. Aesthetic

6.3. Therapeutic

7. Botulinum Toxins Market, by Type

7.1. Introduction

7.2. AbobotulinumtoxinA

7.3. IncobotulinumtoxinA

7.4. OnabotulinumtoxinA

7.5. RimabotulinumtoxinB

8. Americas Botulinum Toxins Market

8.1. Introduction

8.2. Argentina

8.3. Brazil

8.4. Canada

8.5. Mexico

8.6. United States

9. Asia-Pacific Botulinum Toxins Market

9.1. Introduction

9.2. Australia

9.3. China

9.4. India

9.5. Indonesia

9.6. Japan

9.7. Malaysia

9.8. Philippines

9.9. Singapore

9.10. South Korea

9.11. Thailand

10. Europe, Middle East & Africa Botulinum Toxins Market

10.1. Introduction

10.2. France

10.3. Germany

10.4. Italy

10.5. Netherlands

10.6. Qatar

10.7. Russia

10.8. Saudi Arabia

10.9. South Africa

10.10. Spain

10.11. United Arab Emirates

10.12. United Kingdom

11. Competitive Landscape

11.1. FPNV Positioning Matrix

11.1.1. Quadrants

11.1.2. Business Strategy

11.1.3. Product Satisfaction

11.2. Market Ranking Analysis

11.3. Market Share Analysis, By Key Player

11.4. Competitive Scenario

11.4.1. Merger & Acquisition

11.4.2. Agreement, Collaboration, & Partnership

11.4.3. New Product Launch & Enhancement

11.4.4. Investment & Funding

11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles

12.1. AbbVie Inc.

12.2. Ajinomoto Bio-Pharma Services

12.3. Bausch Health Companies Inc.

12.4. Daewoong Pharmaceuticals Co.Ltd.

12.5. Eisai Co., Ltd

12.6. Galderma S.A.

12.7. Gufic Biosciences Ltd.

12.8. Hugel, Inc

12.9. Hugh Source International Ltd.

12.10. Ipsen group


12.12. Lanzhou Institute of Biological Products Co. Ltd.

12.13. List Biological Labs, Inc

12.14. Medytox Inc.

12.15. Merz GmbH & Co. KGaA

12.16. Object Pharma, Inc.

12.17. Pfizer Inc.

12.18. Revance Therapeutics, Inc.

12.19. Shanghai Haohai Biological Technology Co., Ltd.

12.20. US Worldmeds, LLC

13. Appendix

For more information about this report visit

Media Contact:

Research and Markets

Laura Wood, Senior Manager   

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904

Fax (outside U.S.): +353-1-481-1716

Cision View original content:—increasing-number-of-product-approvals-and-launch-of-novel-products-presents-opportunities-301389194.html

SOURCE Research and Markets